ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2152 • 2013 ACR/ARHP Annual Meeting

    Predicting Benefit From Lateral Wedge Orthotics Using Radiographic Parameters In Medial Knee Osteoarthritis

    Berna Goker1, Roy H. Lidtke2, Laura E. Thorp3, Markus A. Wimmer4 and Joel A. Block2, 1Internal Medicine-Rheumatology, Gazi University, Ankara, Turkey, 2Section of Rheumatology, Rush University Medical Center, Chicago, IL, 3Anatomy and Cell Biology, Rush University Medical Center, Chicago, IL, 4Orthopedic Surgery, Rush University Medical Center, Chicago, IL

    Background/Purpose: Lateral wedge foot orthosis have been used therapeutically in patients with medial knee osteoarthritis (OA) with inconsistent results. The current theory suggests they reduce…
  • Abstract Number: 2153 • 2013 ACR/ARHP Annual Meeting

    Arrest Of Progressive Loss Of Vibratory Perception In Knee Osteoarthritis: Effects Of a 48 Week Biomechanical Intervention

    Najia Shakoor1, Roy H. Lidtke2, Louis F. Fogg3, Laura E. Thorp4, Markus A. Wimmer5, Rachel A. Mikolaitis2 and Joel A. Block2, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Section of Rheumatology, Rush University Medical Center, Chicago, IL, 3Department of Nursing, Rush University Medical Center, Chicago, IL, 4Anatomy and Cell Biology, Rush University Medical Center, Chicago, IL, 5Orthopedic Surgery, Rush University Medical Center, Chicago, IL

    Background/Purpose:   Somatosensory function has been shown to be altered in knee osteoarthritis (OA); for example, we previously observed that in knee OA there are…
  • Abstract Number: 2154 • 2013 ACR/ARHP Annual Meeting

    Improvement In Clinical Symptoms After 48 Weeks Of Wearing Flexible Footwear In Osteoarthritis Of Knee: A Randomized Placebo-Controlled Study

    Najia Shakoor1, Roy H. Lidtke2, Louis F. Fogg3, Laura E. Thorp4, Markus A. Wimmer5, Rachel A. Mikolaitis2 and Joel A. Block2, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Section of Rheumatology, Rush University Medical Center, Chicago, IL, 3Department of Nursing, Rush University Medical Center, Chicago, IL, 4Anatomy and Cell Biology, Rush University Medical Center, Chicago, IL, 5Orthopedic Surgery, Rush University Medical Center, Chicago, IL

    Background/Purpose:   Osteoarthritis (OA), the most common form of arthritis, is a major cause of pain and disability.  Biomechanical interventions that reduce dynamic loading are…
  • Abstract Number: 2155 • 2013 ACR/ARHP Annual Meeting

    Beneficial Effect Of Long-Term Use Of a Low-Cost Minimalist Footwear On Joint Load, Clinical, and Functional Aspects Of Elderly Women With Knee Osteoarthritis

    Francis Trombini-Souza1, Alessandra Matias1, Mariane Yokota1, Marco Butugan1, Ivye Pereira1, Claudia Goldenstein-Schainberg2, Ricardo Fuller3 and Isabel C.N. Sacco1, 1Physical Therapy, Speech and Occupational Therapy, School of Medicine, University of São Paulo, São Paulo, Brazil, 2Reumatologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, 3Division of Rheumatology - Hospital das Clinicas - Medical School, University of Sao Paulo, São Paulo, Brazil

    Background/Purpose: Positive outcomes of minimalist shoes on reduction of overload in patients with knee osteoarthritis (OA) have been highlighted. We have recently shown beneficial effects…
  • Abstract Number: 2156 • 2013 ACR/ARHP Annual Meeting

    Weight Change Has A Disease Modifying Effect On Knee Structure and Symptoms In Obese Individuals Without Diagnosed Knee Osteoarthritis

    Andrew Teichtahl1, Anita Wluka2, Stephanie Tanamas3, Yuanyuan Wang3, Boyd Strauss3, Joseph Proietto4, John Dixon5, Graeme Jones6, Andrew Forbes3 and Flavia Cicuttini7, 1Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia, 2Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia, 3Monash University, Melbourne, Australia, 4University of Melbourne, Melbourne, Australia, 5Baker Institute, Melbourne, Australia, 6Menzies Research Institute, Tasmania, Australia, 7Department of Epidemiology and Preventive Medicine, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, 3004, Australia

    Background/Purpose: Although the strongest modifiable risk factor for the development of knee osteoarthritis (OA) is obesity, there are a paucity of data examining the effects…
  • Abstract Number: 2157 • 2013 ACR/ARHP Annual Meeting

    Understanding Differences Between Black and White Patients’ Reactions to New Treatment

    Liana Fraenkel1, Richard L. Street Jr.2 and Ellen Peters3, 1Medicine, Section of Rheumatology, Yale University School of Medicine, Veterans Affairs Connecticut Healthcare System, New Haven, CT, 2Department of Communication, Texas A&M University, College Station, TX, 3Ohio State University, Columbus, OH

    Background/Purpose: Numerous studies have found that Black patients are more risk averse than their White counterparts. In clinical practice, patients make judgments based on oral…
  • Abstract Number: 2158 • 2013 ACR/ARHP Annual Meeting

    Do Numbers Make a Difference?

    Liana Fraenkel1, Evan Wilhelms2 and Valerie Reyna2, 1Medicine, Section of Rheumatology, Yale University School of Medicine, Veterans Affairs Connecticut Healthcare System, New Haven, CT, 2Cornell University, Ithica, NY

    Background/Purpose: Patients frequently overweigh the risks associated with rare adverse events (AEs). This is particularly true for biologics associated with extremely rare AEs. As a…
  • Abstract Number: 2159 • 2013 ACR/ARHP Annual Meeting

    Understanding the Preference to Stay With the Status Quo

    Liana Fraenkel1, Meaghan Cunningham2 and Ellen Peters3, 1Medicine, Section of Rheumatology, Yale University School of Medicine, Veterans Affairs Connecticut Healthcare System, New Haven, CT, 2Medicine, Yale University School of Medicine, New Haven, CT, 3Ohio State University, Columbus, OH

    Background/Purpose: Preference for the status quo is prevalent in patients with rheumatic disease and may be harmful in decisions for which there is strong evidence…
  • Abstract Number: 2161 • 2013 ACR/ARHP Annual Meeting

    Biopsychosocial Typologies of Pain in a Cohort of Patients With Systemic Sclerosis

    Erin L. Merz1, Vanessa L. Malcarne1, Shervin Assassi2, Deepthi Nair2, Tiffany Graham2, Brayden Yellman2, Rosa M. Estrada-Y-Martin3 and Maureen D. Mayes2, 1SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, 2Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, 3Pulmonary and Critical Care Medicine, University of Texas Health Science Center at Houston, Houston, TX

    Background/Purpose: Despite being a common problem in Systemic Sclerosis, the extant literature on pain has primarily focused on biomedical correlates, or bivariate relationships with a…
  • Abstract Number: 2162 • 2013 ACR/ARHP Annual Meeting

    Physical, Psychological, and Social Impacts Of Restricting Back Pain: The Older Person’s Perspective

    Una E. Makris1, Trisha V. Melhado2, Simon C. Lee3, Heidi A. Hamann2, Lisa M. Walke4, Thomas M. Gill4 and Liana Fraenkel5, 1Rheumatology, UT Southwestern Medical Center, VA Medical Center, Dallas, TX, 2Clinical Sciences, UT Southwestern Medical Center, Dallas, TX, 3UT Southwestern Medical Center, Dallas, TX, 4Internal Medicine, Section of Geriatrics, Yale University, New Haven, CT, 5Medicine, Section of Rheumatology, Yale University School of Medicine, Veterans Affairs Connecticut Healthcare System, New Haven, CT

    Background/Purpose: Although back pain is the most common type of pain reported by older adults, we have a limited understanding of its impact on the…
  • Abstract Number: 2163 • 2013 ACR/ARHP Annual Meeting

    Predictors Of No Improvement In Subjective Health Perception In  Newly Diagnosed Rheumatoid Athritis Patients With a Good DAS28 Response At 12 Months In The Dutch Rheumatoid Arthritis Monitoring Tight Control Cohort

    Martijn Oude Voshaar1, Erik Taal2, Peter M. ten Klooster3, Harald E. Vonkeman2,4 and Mart A.F.J. van De Laar5, 1Department of Psychology, Health & Technology, University of Twente, Enschede, Netherlands, 2Psychology, Health and Technology, University of Twente, Enschede, Netherlands, 3Psychology, Health & Technology, University of Twente, Enschede, Netherlands, 4Rheumatology, Medisch Spectrum Twente, Enschede, Netherlands, 5Rheumatology, Medisch Spectrum Twente & University of Twente, Enschede, Netherlands

    Background/Purpose: Modern treatment strategies are highly successful in reducing disease activity in rheumatoid arthritis (RA). However, changes in clinical measures of disease activity may not…
  • Abstract Number: 2164 • 2013 ACR/ARHP Annual Meeting

    Rituximab In The Treatment Of Children With Systemic LUPUS Erythematosus: ONE Year Analysis Of 12 Patients

    Ekaterina Alexeeva1,2, Rina Denisova2, Saniya Valieva2, Tatyana Bzarova2, Kseniya Isayeva2, Tatyana Sleptsova2, Elena Mitenko2, Evgeniya Chistyakova1,2, Anna Fetisova2 and Elena Semikina3, 1I.M.Sechenov First Moscow State Medical University, Moscow, Russia, 2Rheumatology, Scientific Center of Children's Health of RAMS, Moscow, Russia, 3Clinical Laboratory, Scientific Center of Children's Health of RAMS, Moscw, Russia

    Background/Purpose: Treatment of childhood systemic lupus erythematosus (SLE) is an ongoing problem because of the severity of the disease in some patients and the side-effects…
  • Abstract Number: 2165 • 2013 ACR/ARHP Annual Meeting

    Efficacy and Safety Of Biologic Agents In Patients With Poly-Articular Juvenile Idiopathic Arthritis: Network Meta-Analysis Of Randomized Controlled Withdrawal Trials

    Gil Amarilyo1, Simon Tarp2, Ivan Foeldvari3, Neta Cohen4, Tracy D. Pope5, Jennifer M.P. Woo6, Robin Christensen2 and Daniel Furst5, 1Dana-Dwek Children's hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Musculoskeletal Statistics Unit, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, 3Department of Pediatric Rheumatology, Hamburger Zentrum für Kinder und Jugendrheumatologie, Hamburg, Germany, 4Dana-Duek Children's hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 5David Geffen School of Medicine, University of California, Los Angeles, CA, 6Pediatric Rheumatology, Mattel Children's Hospital, University of California, Los Angeles, Los Angeles, CA

    Background/Purpose: Although various biologic agents (BAs) are in use for polyarticular juvenile idiopathic arthritis (pJIA), a combined meta-analytic summary comparing the efficacy and safety among…
  • Abstract Number: 2166 • 2013 ACR/ARHP Annual Meeting

    Infection Risk With Tumor Necrosis Factor Inhibitor Use In Polyarticular Juvenile Idiopathic Arthritis

    Caroline Y Chang1, Rika Meyer2 and Katherine AB Marzan1, 1Division of Rheumatology, Children's Hospital Los Angeles, Los Angeles, CA, 2Children's Hospital Los Angeles, Los Angeles, CA

    Background/Purpose: Tumor Necrosis Factor inhibitors (TNFi) are extremely effective in treating Juvenile Idiopathic Arthritis (JIA).  However, TNF-α is critical in immune function, raising concerns of…
  • Abstract Number: 2167 • 2013 ACR/ARHP Annual Meeting

    23-Valent Polysaccharide Pneumococcal Vaccine in Juvenile Idiopathic Arthritis Patients: Anti-Tumor Necrosis Factor Therapy Role in Short and Long-Term Immunogenicity

    Nadia E. Aikawa1, Ivan L.A. França2, Ana C. M. Ribeiro3, Adriana M. Sallum4, Eloisa Bonfa5 and Clovis A. Silva4, 1Reumatologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, 2Division of Infectious Diseases, University of São Paulo, São Paulo, Brazil, 3Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 4Pediatric Rheumatology Unit, University of São Paulo, São Paulo, Brazil, 5Rheumatology Division, University of São Paulo, Sao Paulo, Brazil

    Background/Purpose: There is no study regarding short and long-term assessments of 23-valent polysaccharide pneumococcal vaccine (PPV23) in juvenile idiopathic arthritis (JIA) under biologic therapy. The objectives…
  • « Previous Page
  • 1
  • …
  • 2287
  • 2288
  • 2289
  • 2290
  • 2291
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology